10x Genomics (TXG) Net Equity Issued and Repurchased (2019 - 2020)
10x Genomics (TXG) reported Net Equity Issued and Repurchased of -$780000.0 for Q4 2020, up 57.95% on a YoY basis from -$493822.5 in Q1 2020, and up 57.95% sequentially from -$1.9 million in Q4 2019.
10x Genomics (TXG) Net Equity Issued and Repurchased (2019 - 2020) Analysis & Trends
10x Genomics (TXG) has 2 years of Net Equity Issued and Repurchased data on file, last reported at -$780000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.90 Bn | 24.59 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 14.63 Bn | 13.73 Bn | 482.22 Mn | - |
| 3 | Healthequity | 8.31 Bn | 8.04 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 5.95 Bn | 5.64 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 5.84 Bn | 5.30 Bn | 106.18 Mn | - |
| 6 | Waystar Holding | 4.49 Bn | 4.42 Bn | 216.84 Mn | - |
| 7 | MiniMed | 4.47 Bn | 4.17 Bn | 480.00 Mn | - |
| 8 | Doximity | 3.96 Bn | 3.22 Bn | 125.97 Mn | - |
| 9 | Privia Health | 3.18 Bn | 2.76 Bn | - | - |
| 10 | Omnicell | 1.86 Bn | 1.62 Bn | 140.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -780,000.00 |
| Dec 31, 2020 | -780,000.00 |
| Dec 31, 2019 | -1.86 Mn |
| Dec 31, 2019 | -1.86 Mn |